Alvotech - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ALVO Nasdaq 2830 www.alvotech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alvotech

Here’s What the Street Thinks About Alvotech (ALVO) - Apr 20th, 2026 3:30 pm
Alvotech (ALVO) Revenue Surges 21% Year-Over-Year in 2025 - Apr 2nd, 2026 12:36 pm
Alvotech files Annual Report with the SEC - Mar 30th, 2026 5:58 pm
Alvotech Publishes 2025 Annual Report - Mar 30th, 2026 5:55 pm
Statutory Earnings May Not Be The Best Way To Understand Alvotech's (NASDAQ:ALVO) True Position - Mar 26th, 2026 4:26 am
Did Alvotech’s (ALVO) Profitability Turn and Expanding Biosimilar Pipeline Just Recast Its Investment Narrative? - Mar 20th, 2026 1:06 am
Alvotech Q4 Earnings Call Highlights - Mar 19th, 2026 7:51 am
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Rising Oil Prices, Reduced Rate-Cut Expectations - Mar 19th, 2026 6:49 am
Alvotech Q4 2025 and Full Year 2025 Financial Results - Mar 18th, 2026 4:15 pm
Alvotech (ALVO) Q4 2025 Earnings Report Preview: What To Look For - Mar 18th, 2026 7:18 am
Alvotech (ALVO) Q4 2025 Earnings Report Preview: What To Expect - Mar 17th, 2026 7:18 am
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results - Mar 4th, 2026 1:00 am
Is Alvotech (ALVO) Pricing Make Sense After A 64% One Year Share Price Slump - Feb 16th, 2026 5:08 am
Alvotech AVT80 Progress And Sandoz Deals Shape Biosimilar Outlook - Feb 16th, 2026 2:08 am
Alvotech (ALVO) Announces Strong Results for Clinical Trial for AVT80 - Feb 15th, 2026 2:08 am
Alvotech Announces Increase in Number of Own Shares - Feb 11th, 2026 9:00 am
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio® - Feb 5th, 2026 1:00 am
Alvotech (ALVO): A Bull Case Theory - Feb 4th, 2026 11:39 am
Assessing Alvotech (ALVO) Valuation After Mixed Short Term Gains And A Steep One Year Decline - Feb 3rd, 2026 5:08 am
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates - Feb 2nd, 2026 1:00 am